GlassScriptPhysician profile
Autumn N Mcgee
NPI 1710345640
$7,121.91
in general payments reported to CMS, 2019-2025
45 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,299 · 2022: $1,105 · 2023: $1,040 · 2024: $1,678 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,717.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,091.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $933.37 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $675.36 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $660.99 | 2021-2025 | |
| Abbvie INC. | $517.04 | 2021-2025 | |
| Glaxosmithkline, LLC. | $487.99 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $315.14 | 2022-2025 | |
| Astellas Pharma US INC | $222.47 | 2023-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $216.51 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $205.74 | 2021-2025 | Triclip, Freestyle Libre 3 |
| Amgen INC. | $174.85 | 2021-2025 | Evenity, Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $143.02 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.74 | 2024-2025 | Jardiance, Synjardy |
| Nestle Healthcare Nutrition INC. | $97.51 | 2021 | |
| Cequr Corporation | $85.07 | 2025 | Cequr Simplicity |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Autumn Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.